HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases

SIMPLE SUMMARY: Tyrosine kinase inhibitors (TKIs) are the treatment of choice for BCR-ABL1-positive chronic myeloid leukemia (CML). Dasatinib is a second generation TKI frequently associated with pleural effusion in up to 33% of patients. Here, we describe two cases of HHV8-negative large B cell eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiori, Stefano, Todisco, Elisabetta, Ramadan, Safaa, Gigli, Federica, Falco, Patrizia, Iurlo, Alessandra, Rampinelli, Cristiano, Croci, Giorgio, Pileri, Stefano A., Tarella, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918666/
https://www.ncbi.nlm.nih.gov/pubmed/33672947
http://dx.doi.org/10.3390/biology10020152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918666/
https://www.ncbi.nlm.nih.gov/pubmed/33672947
http://dx.doi.org/10.3390/biology10020152

Ejemplares similares